Carpal Tunnel Syndrome: Practice Essentials, Pathophysiology, Epidemiology (original) (raw)

Practice Essentials

Carpal tunnel syndrome (CTS) is a collection of characteristic symptoms and signs that occurs following compression of the median nerve within the carpal tunnel. Usual symptoms include numbness, paresthesias, and pain in the median nerve distribution. These symptoms may or may not be accompanied by objective changes in sensation and strength of median-innervated structures in the hand. [1, 2] See image below.

The hands of an 80-year-old woman with a several-y

The hands of an 80-year-old woman with a several-year history of numbness and weakness are shown in this photo. Note severe thenar muscle (abductor pollicis brevis, opponens pollicis) wasting of the right hand, with preservation of hypothenar eminence.

Signs and symptoms of carpal tunnel syndrome

Among the most common complaints, patients will reveal that their hands fall asleep or that things slip from their fingers without their noticing (loss of grip, dropping things); numbness and tingling also are commonly described. Such complaints should be localized to the palmar aspect of the first to the fourth fingers and the distal palm (ie, the sensory distribution of the median nerve at the wrist).

The sensory symptoms above commonly are accompanied by an aching sensation over the ventral aspect of the wrist. This pain can radiate distally to the palm and fingers or, more commonly, extend proximally along the ventral forearm.

Not infrequently, patients report symptoms in the whole hand. Many patients with CTS also complain of a tight or swollen feeling in the hands and/or temperature changes (eg, hands being cold/hot all the time).

Many patients also report sensitivity to changes in temperature (particularly cold) and a difference in skin color. In rare cases, there are complaints of changes in sweating.

Workup in carpal tunnel syndrome

Electrophysiologic studies, [3, 4, 5] including electromyography (EMG) and nerve conductions studies (NCS), are the first-line investigations in suggested CTS. [6] Abnormalities on electrophysiologic testing, in association with specific symptoms and signs, are considered the criterion standard for CTS diagnosis. In addition, other neurologic diagnoses can be excluded with these test results.

Electrophysiologic testing also can provide an accurate assessment of how severe the damage to the nerve is, thereby directing management and providing objective criteria for the determination of prognosis.

Many clinical neurophysiology laboratories are now using ultrasonography as an adjunct to electrodiagnostic studies. Ultrasonography potentially can identify space-occupying lesions in and around the median nerve, confirm abnormalities in the median nerve (eg, increased cross-sectional area) that can be diagnostic of CTS, and help to guide steroid injections into the carpal tunnel. [7, 8, 9]

Magnetic resonance imaging (MRI) of the carpal tunnel is particularly useful preoperatively if a space-occupying lesion in the carpal tunnel is suggested.

Management of carpal tunnel syndrome

Given that CTS is associated with low aerobic fitness and increased body mass index (BMI), it makes some inherent sense to provide the patient with an aerobic fitness and weight-loss program. Stationary biking, cycling, or any other exercise that puts strain on the wrists probably should be avoided. The use of modalities (in particular therapeutic ultrasound) may provide short-term relief in some patients. [10, 11, 12]

Most individuals with mild to moderate CTS (according to electrophysiologic data) respond to conservative management, usually consisting of splinting the wrist at nighttime for a minimum of 3 weeks. [10, 13, 14]

Steroid injection into the carpal tunnel has been shown to be of long-term benefit and can be tried if more conservative treatments have failed. [15]

Patients whose condition does not improve following conservative treatment and patients who initially are in the severe CTS category should be considered for surgery. [16] Surgical release of the transverse ligament provides high initial success rates (greater than 90%), with low rates of complication; however, it has been suggested that the long-term success rate may be much lower than previously thought (approximately 60% at 5 y). Success rates also are considerably lower for individuals with normal electrophysiologic studies. [17, 18, 19]

eMedicine Logo

Pathophysiology

Until the advent of electrophysiologic testing in the 1940s, carpal tunnel syndrome (CTS) commonly was thought to be the result of compression of the brachial plexus by cervical ribs and other structures in the anterior neck region (so-called thoracic outlet syndrome). It is now known that the median nerve is damaged within the rigid confines of the carpal tunnel, initially undergoing demyelination followed by axonal degeneration. Sensory fibers often are affected first, followed by motor fibers. Autonomic nerve fibers carried in the median nerve also may be affected.

The cause of the damage is subject to some debate; however, it seems likely that abnormally high carpal tunnel pressures exist in patients with CTS. This pressure causes obstruction of venous outflow, back pressure, edema formation, and ultimately, ischemia in the nerve.

The risk of development of CTS appears to be associated, at least in part, with a number of different epidemiologic factors, including genetic, medical, social, vocational, avocational, and demographic. [20] A complex interaction probably exists between some or all these factors, eventually leading to the development of CTS. Definite causative factors, however, are far from clear.

eMedicine Logo

Epidemiology

Frequency

United States

The incidence of carpal tunnel syndrome is 1-3 cases per 1000 subjects per year; prevalence is approximately 50 cases per 1000 subjects in the general population. Incidence may rise as high as 150 cases per 1000 subjects per year, with prevalence rates greater than 500 cases per 1000 subjects in certain high-risk groups.

International

A paucity of population-based studies of carpal tunnel syndrome (CTS) exists; however, the incidence and prevalence in developed countries seems similar to the United States (eg, incidence in the Netherlands is approximately 2.5 cases per 1000 subjects per year; prevalence in the United Kingdom is 70-160 cases per 1000 subjects). [21, 22, 23] CTS is almost unheard of in some developing countries (eg, among nonwhite South Africans).

Mortality/Morbidity

Carpal tunnel syndrome is not fatal, but it can lead to complete, irreversible median nerve damage, with consequent severe loss of hand function, if left untreated.

Race

Whites are probably at highest risk of developing carpal tunnel syndrome (CTS). The syndrome appears to be very rare in some racial groups (eg, nonwhite South Africans). [23] In North America, white US Navy personnel have CTS at a rate 2-3 times that of black personnel. [24]

Sex

The female-to-male ratio for carpal tunnel syndrome is 3-10:1.

Age

The peak age range for development of carpal tunnel syndrome (CTS) is 45-60 years. Only 10% of patients with CTS are younger than 31 years.

eMedicine Logo

  1. Chammas M, Boretto J, Burmann LM, Ramos RM, Dos Santos Neto FC, Silva JB. Carpal tunnel syndrome - Part I (anatomy, physiology, etiology and diagnosis). Rev Bras Ortop. 2014 Sep-Oct. 49 (5):429-36. [QxMD MEDLINE Link]. [Full Text].
  2. Chammas M, Boretto J, Burmann LM, Ramos RM, Neto FS, Silva JB. Carpal tunnel syndrome - Part II (treatment). Rev Bras Ortop. 2014 Sep-Oct. 49 (5):437-45. [QxMD MEDLINE Link]. [Full Text].
  3. Robinson LR. Electrodiagnosis of carpal tunnel syndrome. Phys Med Rehabil Clin N Am. 2007 Nov. 18(4):733-46, vi. [QxMD MEDLINE Link].
  4. Practice parameter for electrodiagnostic studies in carpal tunnel syndrome: summary statement. American Association of Electrodiagnostic Medicine, American Academy of Neurology, American Academy of Physical Medicine and Rehabilitation. Muscle Nerve. 1993 Dec. 16(12):1390-1. [QxMD MEDLINE Link].
  5. Stevens JC. AAEM minimonograph #26: the electrodiagnosis of carpal tunnel syndrome. American Association of Electrodiagnostic Medicine. Muscle Nerve. 1997 Dec. 20(12):1477-86. [QxMD MEDLINE Link].
  6. Chang MH, Lee YC, Hsieh PF. The real role of forearm mixed nerve conduction velocity in the assessment of proximal forearm conduction slowing in carpal tunnel syndrome. J Clin Neurophysiol. 2008 Nov 6. [QxMD MEDLINE Link].
  7. Lee D, van Holsbeeck MT, Janevski PK, et al. Diagnosis of carpal tunnel syndrome. Ultrasound versus electromyography. Radiol Clin North Am. 1999 Jul. 37(4):859-72, x. [QxMD MEDLINE Link].
  8. Tai TW, Wu CY, Su FC, Chern TC, Jou IM. Ultrasonography for diagnosing carpal tunnel syndrome: a meta-analysis of diagnostic test accuracy. Ultrasound Med Biol. 2012 Jul. 38(7):1121-8. [QxMD MEDLINE Link].
  9. Cartwright MS. Ultrasound of focal neuropathies. Walker FO, Cartwright MS, eds. Neuromuscular Ultrasound. Philadelphia, Pa: Elsevier Saunders; 2011. 74-76.
  10. Banta CA. A prospective, nonrandomized study of iontophoresis, wrist splinting, and antiinflammatory medication in the treatment of early-mild carpal tunnel syndrome. J Occup Med. 1994 Feb. 36(2):166-8. [QxMD MEDLINE Link].
  11. Page MJ, O'Connor D, Pitt V, Massy-Westropp N. Therapeutic ultrasound for carpal tunnel syndrome. Cochrane Database Syst Rev. 2012 Jan 18. 1:CD009601. [QxMD MEDLINE Link].
  12. O'Connor D, Marshall S, Massy-Westropp N. Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome. Cochrane Database Syst Rev. 2003. CD003219. [QxMD MEDLINE Link].
  13. Ugurlu U, Ozkan M, Ozdogan H. The development of a new orthosis (neuro-orthosis) for patients with carpal tunnel syndrome: its effect on the function and strength of the hand. Prosthet Orthot Int. 2008 Dec. 32(4):403-21. [QxMD MEDLINE Link].
  14. Page MJ, Massy-Westropp N, O'Connor D, Pitt V. Splinting for carpal tunnel syndrome. Cochrane Database Syst Rev. 2012 Jul 11. 7:CD010003. [QxMD MEDLINE Link].
  15. Marshall S, Tardif G, Ashworth N. Local corticosteroid injection for carpal tunnel syndrome. Cochrane Database Syst Rev. 2007. (2):CD001554. [QxMD MEDLINE Link].
  16. Carpal Tunnel Syndrome: Physical Therapy or Surgery?. J Orthop Sports Phys Ther. 2017 Mar. 47 (3):162. [QxMD MEDLINE Link]. [Full Text].
  17. Scholten RJ, Mink van der Molen A, Uitdehaag BM, et al. Surgical treatment options for carpal tunnel syndrome. Cochrane Database Syst Rev. 2007. (4):CD003905. [QxMD MEDLINE Link].
  18. Boya H, Ozcan O, Oztekin HH. Long-term complications of open carpal tunnel release. Muscle Nerve. 2008 Nov. 38(5):1443-6. [QxMD MEDLINE Link].
  19. Verdugo RJ, Salinas RA, Castillo JL, Cea JG. Surgical versus non-surgical treatment for carpal tunnel syndrome. Cochrane Database Syst Rev. 2008 Oct 8. CD001552. [QxMD MEDLINE Link].
  20. de Krom MC, Kester AD, Knipschild PG, et al. Risk factors for carpal tunnel syndrome. Am J Epidemiol. 1990 Dec. 132(6):1102-10. [QxMD MEDLINE Link].
  21. Atroshi I, Gummesson C, Johnsson R, et al. Prevalence of carpal tunnel syndrome in a general population. JAMA. 1999 Jul 14. 282(2):153-8. [QxMD MEDLINE Link]. [Full Text].
  22. de Krom MC, Knipschild PG, Kester AD, et al. Carpal tunnel syndrome: prevalence in the general population. J Clin Epidemiol. 1992 Apr. 45(4):373-6. [QxMD MEDLINE Link].
  23. Goga IE. Carpal tunnel syndrome in black South Africans. J Hand Surg [Br]. 1990 Feb. 15(1):96-9. [QxMD MEDLINE Link].
  24. Garland FC, Garland CF, Doyle EJ Jr, et al. Carpal tunnel syndrome and occupation in U.S. Navy enlisted personnel. Arch Environ Health. 1996 Sep-Oct. 51(5):395-407. [QxMD MEDLINE Link].
  25. Durkan JA. The carpal-compression test. An instrumented device for diagnosing carpal tunnel syndrome. Orthop Rev. 1994 Jun. 23(6):522-5. [QxMD MEDLINE Link].
  26. Kao SY. Carpal tunnel syndrome as an occupational disease. J Am Board Fam Pract. 2003 Nov-Dec. 16(6):533-42. [QxMD MEDLINE Link]. [Full Text].
  27. Palmer KT, Harris EC, Coggon D. Carpal tunnel syndrome and its relation to occupation: a systematic literature review. Occup Med (Lond). 2007 Jan. 57(1):57-66. [QxMD MEDLINE Link].
  28. Bernard PB, ed. Musculoskeletal Disorders and Workplace Factors: A Critical Review of Epidemiologic Evidence for Work-Related Musculoskeletal Disorders of the Neck, Upper Extremity, and Low Back. National Institute for Occupational Safety and Health. Jul 1997. Available at https://www.cdc.gov/niosh/docs/97-141/.
  29. Fernandez-Munoz JJ, Palacios-Cena M, Cigaran-Mendez M, et al. Pain is Associated to Clinical, Psychological, Physical, and Neuro-physiological Variables in Women with Carpal Tunnel Syndrome. Clin J Pain. 2015 Apr 15. [QxMD MEDLINE Link].
  30. Yeh KT, Lee RP, Yu TC, et al. Risk factors for carpal tunnel syndrome or trigger finger following distal radius fracture: a nationwide study. Sci Rep. 2020 Jan 16. 10 (1):469. [QxMD MEDLINE Link]. [Full Text].
  31. Zagnoli F, Andre V, Le Dreff P, et al. Idiopathic carpal tunnel syndrome. Clinical, electrodiagnostic, and magnetic resonance imaging correlations. Rev Rhum Engl Ed. 1999 Apr. 66(4):192-200. [QxMD MEDLINE Link].
  32. Incebiyik S, Boyaci A, Tutoglu A. Short-term effectiveness of short-wave diathermy treatment on pain, clinical symptoms, and hand function in patients with mild or moderate idiopathic carpal tunnel syndrome. J Back Musculoskelet Rehabil. 2014 Jul 24. [QxMD MEDLINE Link].
  33. Page MJ, O'Connor D, Pitt V, Massy-Westropp N. Exercise and mobilisation interventions for carpal tunnel syndrome. Cochrane Database Syst Rev. 2012 Jun 13. 6:CD009899. [QxMD MEDLINE Link].
  34. O'Connor D, Page MJ, Marshall SC, Massy-Westropp N. Ergonomic positioning or equipment for treating carpal tunnel syndrome. Cochrane Database Syst Rev. 2012 Jan 18. 1:CD009600. [QxMD MEDLINE Link].
  35. Goodyear-Smith F, Arroll B. What can family physicians offer patients with carpal tunnel syndrome other than surgery? A systematic review of nonsurgical management. Ann Fam Med. 2004 May-Jun. 2(3):267-73. [QxMD MEDLINE Link]. [Full Text].
  36. Meys V, Thissen S, Rozeman S, Beekman R. Prognostic factors in carpal tunnel syndrome treated with a corticosteroid injection. Muscle Nerve. 2011 Nov. 44(5):763-8. [QxMD MEDLINE Link].
  37. Chen PC, Wang LY, Pong YP, Hsin YJ, Liaw MY, Chiang CW. Effectiveness of ultrasound-guided vs direct approach corticosteroid injections for carpal tunnel syndrome: A double-blind randomized controlled trial. J Rehabil Med. 2018 Feb 13. 50 (2):200-8. [QxMD MEDLINE Link]. [Full Text].
  38. Adindu E, Ramtin S, Azarpey A, Ring D, Teunis T. Steroid versus placebo injections and wrist splints in patients with carpal tunnel syndrome: a systematic review and network meta-analysis. J Hand Surg Eur Vol. 2024 Mar 28. 17531934241240380. [QxMD MEDLINE Link]. [Full Text].
  39. Chan PYW, Santana A, Alter T, Shiffer M, Kalahasti S, Katt BM. Long-term Efficacy of Corticosteroid Injection for Carpal Tunnel Syndrome: A Systematic Review. Hand (N Y). 2024 Jan 19. 15589447231222320. [QxMD MEDLINE Link].
  40. Raeissadat SA, Shahraeeni S, Sedighipour L, Vahdatpour B. Randomized controlled trial of local progesterone vs corticosteroid injection for carpal tunnel syndrome. Acta Neurol Scand. 2017 Feb 22. [QxMD MEDLINE Link].
  41. Eftekharsadat B, Babaei-Ghazani A, Habibzadeh A. The Efficacy of 100 and 300 mg Gabapentin in the Treatment of Carpal Tunnel Syndrome. Iran J Pharm Res. 2015 Fall. 14 (4):1275-80. [QxMD MEDLINE Link]. [Full Text].
  42. Hui AC, Wong SM, Leung HW, Man BL, Yu E, Wong LK. Gabapentin for the treatment of carpal tunnel syndrome: a randomized controlled trial. Eur J Neurol. 2011 May. 18 (5):726-30. [QxMD MEDLINE Link].
  43. [Guideline] American Academy of Orthopaedic Surgeons. Management of carpal tunnel syndrome: evidence-based clinical practice guideline. Available at https://www.aaos.org/uploadedFiles/PreProduction/Quality/Guidelines_and_Reviews/guidelines/CTS%20CPG_2.29.16.pdf. Feb 29, 2016; Accessed: May 23, 2018.
  44. Meyers A, Annunziata MJ, Rampazzo A, Bassiri Gharb B. A Systematic Review of the Outcomes of Carpal Ligament Release in Severe Carpal Tunnel Syndrome. J Hand Surg Am. 2022 Jan 18. [QxMD MEDLINE Link].
  45. Rivlin M, Kachooei AR, Wang ML, Ilyas AM. Electrodiagnostic Grade and Carpal Tunnel Release Outcomes: A Prospective Analysis. J Hand Surg Am. 2018 Jan 31. [QxMD MEDLINE Link].
  46. Rozanski M, Neuhaus V, Thornton E, Becker SJ, Rathmell JP, Ring D. Symptoms During or Shortly After Isolated Carpal Tunnel Release and Problems Within 24 hours After Surgery. J Hand Microsurg. 2015 Jun. 7 (1):30-5. [QxMD MEDLINE Link].
  47. Pace GI, Zale CL, Gendelberg D, Taylor KF. Self-Reported Outcomes for Patients Undergoing Revision Carpal Tunnel Surgery With or Without Hypothenar Fat Pad Transposition. Hand (N Y). 2017 Mar 1. 1558944717701243. [QxMD MEDLINE Link].

Author

Nigel L Ashworth, MBChB, MSc, FRCPC Professor, Divisions of Physical Medicine and Rehabilitation and Neurology, University of Alberta Faculty of Medicine and Dentistry, Canada

Nigel L Ashworth, MBChB, MSc, FRCPC is a member of the following medical societies: American Association of Neuromuscular and Electrodiagnostic Medicine, Australian & New Zealand Association of Neurologists, British Medical Association, Canadian Medical Association, Canadian Society of Clinical Neurophysiologists, Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Patrick M Foye, MD Director of Coccyx Pain Center, Professor of Physical Medicine and Rehabilitation, Rutgers New Jersey Medical School; Co-Director of Musculoskeletal Fellowship, Co-Director of Back Pain Clinic, University Hospital

Patrick M Foye, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation

Disclosure: Nothing to disclose.

Chief Editor

Milton J Klein, DO, MBA Community Medical Staff Physiatrist, Heritage Valley Health System-Sewickley Hospital

Milton J Klein, DO, MBA is a member of the following medical societies: American Academy of Disability Evaluating Physicians, American Academy of Medical Acupuncture, American Academy of Osteopathy, American Academy of Physical Medicine and Rehabilitation, American Medical Association, American Osteopathic Association, American Osteopathic College of Physical Medicine and Rehabilitation, American Pain Society, Pennsylvania Medical Society

Disclosure: Nothing to disclose.

Additional Contributors

Benjamin M Sucher, DO, FAOCPMR, FAAPMR Medical Director, EMG Labs of AARA (Arizona Arthritis and Rheumatology Associates)

Benjamin M Sucher, DO, FAOCPMR, FAAPMR is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine, American Osteopathic Association, American Osteopathic College of Physical Medicine and Rehabilitation, Arizona Society of Physical Medicine and Rehabilitation

Disclosure: Nothing to disclose.